KFY Stock Cash Flow Statements

Korn Ferry Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Korn Ferry Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31	2023-04-30	2023-01-31	2022-10-31	2022-07-31	2022-04-30	2022-01-31	2021-10-31	2021-07-31	2021-04-30	2021-01-31	2020-10-31	2020-07-31	2020-04-30	2020-01-31	2019-10-31	2019-07-31	2019-04-30	2019-01-31	2018-10-31	2018-07-31	2018-04-30	2018-01-31	2017-10-31	2017-07-31	2017-04-30	2017-01-31	2016-10-31	2016-07-31	2016-04-30	2016-01-31	2015-10-31	2015-07-31	2015-04-30	2015-01-31	2014-10-31	2014-07-31	2014-04-30	2014-01-31	2013-10-31	2013-07-31	2013-04-30	2013-01-31	2012-10-31	2012-07-31	2012-04-30	2012-01-31	2011-10-31	2011-07-31	2011-04-30	2011-01-31	2010-10-31	2010-07-31	2010-04-30	2010-01-31	2009-10-31	2009-07-31	2009-04-30	2009-01-31	2008-10-31	2008-07-31	2008-04-30	2008-01-31	2007-10-31	2007-07-31	2007-04-30	2007-01-31	2006-10-31	2006-07-31	2006-04-30	2006-01-31	2005-10-31	2005-07-31	2005-04-30	2005-01-31	2004-10-31	2004-07-31	2004-04-30	2004-01-31	2003-04-30	2003-01-31	2002-10-31	2002-07-31	2002-04-30

cash flows from operating activities:
net income	67,434,000	65,138,000	59,339,000	62,343,000	64,256,000	65,612,000	59,720,000	44,000	47,185,000	48,134,000	11,769,000	74,615,000	78,536,000	93,059,000	85,057,000	76,332,000	76,397,000	66,751,000	51,588,000	28,078,000	-30,855,000	-621,000	20,956,000	43,032,000	43,650,000	50,627,000	45,444,000	47,317,000	-38,592,000	42,309,000	27,427,000	36,732,000	29,429,000	27,736,000	24,378,000	31,056,000	4,068,000	6,375,000	-15,995,000	17,971,000	23,082,000	25,482,000	22,939,000	25,403,000	14,533,000	21,211,000	21,304,000	18,759,000	11,417,000	12,197,000	9,482,000	1,196,000	10,418,000	12,028,000	11,717,000	15,147,000	15,411,000	20,339,000	13,975,000	13,656,000	10,904,000	8,916,000	7,910,000	2,745,000	-14,273,000	-17,200,000	-22,356,000	13,560,000	15,904,000	15,746,000	16,256,000	17,109,000	17,100,000	13,539,000	14,730,000	13,566,000	13,663,000	20,300,000	16,613,000	10,904,000	11,613,000	11,715,000	9,824,000	8,710,000	8,371,000	8,734,000	3,885,000	-1,743,000	-2,559,000	-18,017,000	-583,000	-13,272,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	22,686,000	20,531,000	20,490,000	19,688,000	19,578,000	19,891,000	19,509,000	19,554,000	19,012,000	17,976,000	17,037,000	17,093,000	16,229,000	16,140,000	16,104,000	15,633,000	15,644,000	15,777,000	15,735,000	15,298,000	15,035,000	14,956,000	14,863,000	12,715,000	12,777,000	11,999,000	11,741,000	11,018,000	11,731,000	11,707,000	12,225,000	12,447,000	12,209,000	12,290,000	11,774,000	11,752,000	11,444,000	11,287,000	10,330,000	7,180,000	7,423,000	7,234,000	6,814,000	6,779,000	6,770,000	7,315,000	6,333,000	6,580,000	5,944,000	5,877,000	5,088,000	4,297,000	3,742,000	3,650,000	3,523,000	3,475,000	3,369,000	3,320,000	3,239,000	3,144,000	2,968,000	3,049,000	2,755,000	2,860,000	2,829,000	2,946,000	2,925,000	2,880,000	2,832,000	2,740,000	2,812,000	2,539,000	2,350,000	2,066,000	2,557,000	2,368,000	2,289,000	2,405,000	2,177,000	2,219,000	2,201,000	1,713,000	2,341,000	2,140,000	2,242,000
stock-based compensation expense	11,009,000	14,497,000	11,301,000	11,380,000	10,783,000	9,710,000	10,307,000	11,225,000	8,728,000	9,375,000	9,484,000	9,669,000	7,757,000	7,235,000	7,326,000	7,491,000	7,158,000	6,947,000	7,015,000	7,230,000	5,965,000	5,830,000	5,468,000	6,058,000	5,462,000	5,357,000	5,659,000	6,655,000	5,714,000	5,669,000	5,517,000	5,587,000	4,696,000	4,857,000	4,581,000	4,605,000	4,915,000	5,356,000	4,526,000	5,322,000	3,691,000	3,521,000	3,419,000	3,640,000	3,319,000	3,287,000	3,027,000	2,832,000	2,960,000	3,086,000	2,551,000	3,073,000	3,196,000	3,486,000	3,316,000	3,427,000	3,170,000	3,772,000	3,969,000	3,991,000	3,815,000	4,457,000	4,024,000	4,752,000	4,496,000	3,905,000	3,868,000
deferred income taxes	6,499,000	-12,368,000	-9,309,000	5,597,000	9,676,000	-13,491,000	-20,043,000	-6,709,000	7,934,000	-5,321,000	-8,265,000	-4,648,000	3,831,000	-14,259,000	-5,710,000	-1,581,000	4,587,000	-11,079,000	-8,132,000	999,000	4,072,000	-7,356,000	-8,376,000	4,428,000	1,974,000	-4,604,000	-3,354,000	2,726,000	-22,564,000	-11,937,000	-2,429,000	-760,000	8,562,000	-1,223,000	1,979,000	423,000	5,410,000	-21,972,000	-3,757,000	1,692,000	5,124,000	-1,365,000	-1,595,000	-2,215,000	4,859,000	2,679,000	970,000	593,000	3,356,000	-9,076,000	3,726,000	-1,678,000	6,852,000	-7,025,000	12,006,000	157,000	1,374,000	4,004,000	-3,735,000	-1,254,000	6,939,000	-9,982,000	-3,768,000	-4,072,000	-3,040,000	-14,652,000	4,741,000	1,183,000	4,374,000		-1,533,000	-2,366,000	-4,244,000		-1,470,000	-1,379,000	-3,438,000		-1,395,000	-1,027,000	-3,139,000		-2,849,000
benefit from doubtful accounts	4,793,000	7,758,000	4,491,000	3,317,000	5,110,000	3,511,000	5,417,000	5,822,000	5,965,000	5,768,000	5,707,000	5,472,000	5,546,000	6,523,000	5,400,000	5,030,000	4,599,000	4,202,000	3,568,000	3,367,000	4,626,000	3,686,000	3,808,000	3,601,000	3,549,000	3,248,000	3,541,000	3,764,000	3,707,000	3,742,000	2,973,000	3,890,000	3,070,000	4,614,000	3,222,000	2,574,000	2,577,000	1,914,000	2,267,000	2,321,000	2,068,000	2,097,000	1,874,000	1,859,000	1,911,000	2,096,000	2,657,000	1,645,000	1,442,000	1,930,000	1,673,000	1,758,000	1,387,000	191,000	1,572,000	2,012,000	1,957,000	1,667,000	1,709,000	2,448,000	1,826,000	-170,000	2,066,000	788,000	656,000	1,904,000	2,352,000	3,232,000	1,639,000	967,000	2,812,000	3,464,000	3,056,000	-214,000	2,693,000	2,308,000	1,796,000	1,682,000	922,000	2,052,000	1,819,000	-899,000	2,194,000	2,124,000	2,062,000	-265,000	1,466,000	1,333,000	391,000	2,066,000	2,056,000	1,344,000
gain on marketable securities	-12,324,000	10,887,000			-14,185,000				-12,796,000		-12,651,000	9,749,000	-58,000	14,344,000	7,675,000	-4,799,000	-5,242,000		-15,151,000	-475,000	-11,550,000	10,407,000			-1,945,000	-6,804,000	-2,166,000	4,837,000	-4,001,000		-7,225,000	-3,368,000	-3,429,000				-3,915,000	-5,571,000	7,086,000	2,483,000	-665,000	-4,501,000	199,000	-2,509,000	-2,018,000	-1,920,000	-1,209,000
gain on cash surrender value of life insurance policies	-2,569,000	-4,344,000	-2,464,000	-2,543,000	-2,246,000	-2,359,000	-2,497,000	-1,981,000	-1,966,000	-3,137,000	-2,549,000	-2,861,000	-2,029,000	-1,922,000	-1,713,000	-1,653,000	-531,000	-4,442,000	-4,676,000	-1,794,000	-2,105,000	-757,000	-1,585,000	-1,871,000	-2,338,000	-1,613,000	-1,544,000	-1,656,000	-1,347,000	-1,756,000	-1,793,000	-1,742,000	-2,485,000	-1,602,000	-144,000	-674,000	-2,498,000	-2,183,000	1,494,000	-801,000	-2,494,000	-2,011,000	-3,004,000	-2,231,000	-3,263,000	-1,810,000	-1,845,000	-3,296,000	-1,291,000	-2,266,000	-2,058,000	-1,507,000	-671,000	-2,884,000	-2,209,000	-142,000	-1,033,000		-1,413,000	-2,775,000	-207,000					-221,000	-206,000	3,803,000	202,000		2,037,000	-3,082,000	-863,000		-1,538,000	-2,092,000	-60,000		-1,787,000	-412,000	-1,990,000		-2,242,000
change in other assets and liabilities:
deferred compensation	27,763,000	1,602,000	18,843,000	-1,921,000	22,938,000	15,793,000	33,743,000	-11,587,000	27,453,000	9,664,000	23,756,000	-4,598,000	23,469,000	-4,995,000	1,853,000	12,478,000	17,861,000	18,781,000	22,554,000	3,338,000	19,332,000	-3,150,000	11,829,000	3,165,000	11,652,000	12,992,000	7,132,000	-4,667,000	3,021,000	2,073,000	13,027,000	4,272,000	8,288,000	6,890,000	6,782,000	-938,000	-5,866,000	-891,000	-2,390,000	496,000	-1,820,000	7,284,000	-2,724,000	3,855,000	1,715,000	3,671,000	1,143,000	5,936,000	1,436,000	7,235,000	4,354,000	3,026,000	-6,138,000	5,853,000	1,608,000	-1,759,000	-1,915,000	6,958,000	-2,457,000	3,239,000	3,976,000	7,828,000	-8,595,000	2,745,000	13,850,000	1,967,000	-823,000	-9,663,000	5,434,000	1,575,000	-1,000	4,442,000	8,343,000	6,160,000	3,124,000	3,177,000	7,109,000	2,492,000	2,890,000	1,692,000	5,582,000	-283,000	2,341,000	1,552,000	940,000	862,000	-439,000	1,252,000	1,177,000	1,026,000	1,683,000	1,042,000
receivables due from clients	-39,900,000	2,690,000	11,176,000	-9,994,000	-37,115,000	45,192,000	-2,926,000	-5,697,000	-28,697,000	69,222,000	36,008,000	-19,400,000	-52,347,000	17,222,000	13,188,000	-100,250,000	-68,787,000	-4,487,000	-16,623,000	-63,603,000	17,382,000	71,410,000	23,298,000	-29,106,000	-31,450,000	13,707,000	8,204,000	-36,266,000	-16,270,000	9,107,000	-3,444,000	-35,607,000	-23,413,000	-6,823,000	14,461,000	-21,378,000	-28,586,000	15,669,000	13,997,000	-33,230,000	-13,058,000	13,931,000	8,358,000	-11,190,000	-28,312,000	12,900,000	5,608,000	-18,715,000	-22,111,000	1,432,000	5,561,000	-10,838,000	-12,166,000
income taxes and other receivables	-8,539,000	19,058,000	731,000	-5,075,000	-9,003,000	22,381,000	-921,000	-7,627,000	-164,000	824,000	-14,219,000	-9,789,000	-2,431,000	9,791,000	-4,234,000	-4,115,000	2,527,000	5,881,000	13,672,000	-10,866,000	-2,889,000	3,000	7,044,000	-10,292,000	-3,176,000	2,551,000	-1,487,000	8,156,000	-7,811,000
prepaid expenses and other assets	-16,825,000	3,718,000	2,768,000	8,534,000	-7,023,000	-81,000	4,364,000	3,517,000	-8,039,000	-8,458,000	6,783,000	7,391,000	-11,600,000	-872,000	-2,332,000	3,995,000	-10,325,000	-2,011,000	2,244,000	3,999,000	-8,134,000	8,235,000	-1,051,000	1,705,000	-9,845,000	331,000	4,847,000	-970,000	-4,356,000	-1,624,000	3,400,000	-4,284,000	-10,983,000	397,000	-698,000	1,882,000	-10,066,000	250,000	890,000	-2,581,000	-4,869,000	195,000	1,198,000	371,000	-2,909,000	-145,000	1,263,000	1,604,000	-3,977,000	1,785,000	662,000	217,000	-1,914,000	-280,000
unearned compensation	-20,236,000	4,349,000	13,565,000	-10,982,000	-16,386,000	12,197,000	10,533,000	6,906,000	-21,713,000	3,774,000	13,915,000	-6,700,000	915,000	9,541,000	11,989,000	-7,681,000	-37,274,000	2,276,000	-1,581,000	-9,313,000	-24,317,000	17,693,000	9,183,000	-11,758,000	-14,818,000	7,798,000	6,006,000	-3,640,000	-17,463,000
income taxes payable	125,000	2,015,000	5,107,000	-11,507,000	-964,000	-793,000	3,026,000	-3,094,000	3,478,000	2,188,000	-10,910,000	-10,469,000	3,887,000	7,490,000	7,093,000	-7,368,000	5,536,000	11,298,000	-1,158,000	-555,000	-11,409,000	2,690,000	4,695,000	-4,228,000	-1,911,000	745,000	5,366,000	-7,332,000	1,434,000	14,222,000	8,758,000	2,996,000	6,463,000	3,628,000	2,480,000	-1,634,000	-4,346,000	5,142,000	-5,516,000	3,263,000	-1,990,000	-4,195,000	-226,000	194,000	-4,967,000	139,000	3,623,000	1,757,000	2,014,000	-90,000	325,000	474,000	-4,108,000	1,387,000	526,000	2,415,000	-270,000	-7,152,000	3,301,000	3,189,000	-1,024,000	2,293,000	-5,979,000	4,905,000	1,625,000	1,045,000	-13,553,000	-4,181,000	-2,220,000	-7,032,000	-7,269,000	-7,963,000	16,982,000	-6,135,000	4,185,000	4,363,000	2,765,000	-9,048,000	4,184,000	1,915,000	4,515,000	-1,701,000	6,532,000
accounts payable and accrued liabilities	-276,906,000	125,779,000	87,077,000	57,285,000	-272,117,000	92,847,000	69,023,000	104,909,000	-321,491,000	100,775,000	107,133,000	66,560,000	-302,289,000	120,974,000	127,325,000	116,668,000	-173,520,000	100,128,000	75,181,000	71,159,000	-123,781,000	53,900,000	73,533,000	42,265,000	-175,709,000	61,474,000	43,468,000	58,861,000	-135,405,000	81,650,000	50,520,000	42,945,000	-109,034,000	51,311,000	39,242,000	8,733,000	-93,866,000	48,046,000	39,903,000	27,650,000	-96,737,000	44,689,000	29,360,000	21,377,000	-77,636,000	45,820,000	28,212,000	17,872,000	-62,800,000	30,955,000	18,535,000	33,498,000	-74,494,000	37,076,000	6,427,000	14,166,000	-75,655,000	31,587,000	16,245,000	33,441,000	-41,164,000	31,908,000	8,091,000	7,461,000	-48,243,000	10,470,000	2,611,000	1,923,000	-97,240,000	55,547,000	49,070,000	35,928,000	-92,743,000	47,903,000	29,527,000	20,711,000	-53,813,000	35,532,000	22,202,000	12,427,000	-54,691,000	29,775,000	20,225,000	18,112,000	-19,059,000	15,492,000	11,350,000	14,926,000	893,000	2,296,000	-28,781,000	14,647,000
other	-377,000	-5,497,000	-3,270,000	613,000	-487,000	-1,507,000	-1,429,000	2,037,000	-1,128,000	240,000	-1,342,000	1,084,000	-1,302,000	-90,000	-5,020,000	-1,466,000	825,000	-1,541,000	2,119,000	5,350,000	4,366,000	2,286,000	136,000	-717,000	209,000	160,000	351,000	-3,400,000	-1,816,000	3,089,000	-4,759,000	-13,358,000	-21,986,000	1,090,000	-1,384,000	5,128,000	-7,137,000	7,368,000	4,962,000	-3,837,000	-10,368,000	-1,734,000	-2,738,000	-759,000	-3,735,000	1,026,000	310,000	1,296,000	-5,794,000	2,597,000	652,000	1,994,000	-1,070,000	2,120,000	4,195,000	3,794,000	-2,867,000	433,000	-191,000	-1,002,000	-139,000	-1,757,000	-1,410,000	-3,323,000	-1,066,000	20,133,000	1,995,000	-480,000	-71,000	-3,730,000	316,000	-2,672,000	79,000	-904,000	-663,000	-1,520,000	-145,000	-390,000	-945,000	223,000	309,000	1,186,000	-34,000	-3,068,000	-604,000	381,000	-738,000	-2,219,000	2,524,000	4,960,000	1,292,000
net cash from operating activities	-237,367,000	255,813,000	213,736,000	121,998,000	-227,185,000	261,856,000	164,001,000	132,591,000	-274,487,000	251,110,000	191,502,000	133,168,000	-231,886,000	280,181,000	264,001,000	118,021,000	-160,545,000	197,128,000	146,355,000	52,212,000	-144,262,000	179,212,000	161,235,000			157,848,000	133,146,000	85,303,000	-117,492,000	159,533,000	115,752,000	53,413,000	-109,573,000	92,373,000	102,323,000	47,406,000	-136,038,000	81,452,000	56,070,000	16,752,000	-90,193,000	89,191,000	70,100,000	38,032,000	-90,047,000	96,406,000	68,683,000	31,722,000	-67,329,000			31,197,000	-74,530,000	67,052,000	39,143,000	47,763,000	-82,983,000	68,992,000	34,333,000	33,105,000	-40,796,000	39,916,000	-1,972,000	-2,416,000	-66,374,000	38,125,000	29,117,000	24,800,000	-88,871,000	85,806,000	67,075,000	30,016,000	-73,386,000	71,639,000	44,373,000	33,413,000	-47,094,000	64,587,000			-46,630,000	49,677,000	31,928,000	27,886,000	-21,708,000	28,895,000	13,365,000	15,762,000	12,881,000	2,612,000	-6,760,000	17,057,000
capex	-22,599,000	-20,293,000	-17,384,000	-14,310,000	-10,497,000	-11,860,000	-11,749,000	-15,879,000	-15,659,000	-16,333,000	-17,182,000	-20,221,000	-16,646,000	-16,747,000	-13,671,000	-9,978,000	-9,010,000	-8,280,000	-7,513,000	-6,542,000	-8,787,000	-7,707,000	-9,936,000			-9,796,000	-12,321,000	-11,402,000	-13,163,000	-10,867,000	-10,320,000	-11,284,000	-9,529,000	-8,472,000	-9,294,000	-17,243,000	-15,079,000	-8,471,000	-7,028,000	-5,160,000	-5,485,000	-6,255,000	-4,300,000	-4,715,000	-6,590,000	-11,252,000	-5,836,000	-6,288,000	-5,183,000			-3,595,000	-3,011,000	-5,030,000	-4,839,000	-3,556,000	-5,207,000	-5,505,000	-5,121,000	-5,579,000	-11,684,000	-2,905,000	-1,654,000	-1,538,000	-1,185,000	-1,647,000	-3,886,000	-3,519,000	-2,895,000	-4,127,000	-4,799,000	-4,975,000	-3,075,000	-5,859,000	-2,298,000	-3,245,000	-2,706,000	-3,107,000			-2,847,000	-2,220,000	-2,518,000	-1,788,000	-999,000	-746,000	-233,000	-2,797,000	-381,000	-87,000	-190,000	-207,000
free cash flows	-259,966,000	235,520,000	196,352,000	107,688,000	-237,682,000	249,996,000	152,252,000	116,712,000	-290,146,000	234,777,000	174,320,000	112,947,000	-248,532,000	263,434,000	250,330,000	108,043,000	-169,555,000	188,848,000	138,842,000	45,670,000	-153,049,000	171,505,000	151,299,000			148,052,000	120,825,000	73,901,000	-130,655,000	148,666,000	105,432,000	42,129,000	-119,102,000	83,901,000	93,029,000	30,163,000	-151,117,000	72,981,000	49,042,000	11,592,000	-95,678,000	82,936,000	65,800,000	33,317,000	-96,637,000	85,154,000	62,847,000	25,434,000	-72,512,000			27,602,000	-77,541,000	62,022,000	34,304,000	44,207,000	-88,190,000	63,487,000	29,212,000	27,526,000	-52,480,000	37,011,000	-3,626,000	-3,954,000	-67,559,000	36,478,000	25,231,000	21,281,000	-91,766,000	81,679,000	62,276,000	25,041,000	-76,461,000	65,780,000	42,075,000	30,168,000	-49,800,000	61,480,000			-49,477,000	47,457,000	29,410,000	26,098,000	-22,707,000	28,149,000	13,132,000	12,965,000	12,500,000	2,525,000	-6,950,000	16,850,000
cash flows from investing activities:
purchase of property and equipment	-22,599,000	-20,293,000	-17,384,000	-14,310,000	-10,497,000	-11,860,000	-11,749,000	-15,879,000	-15,659,000	-16,333,000	-17,182,000	-20,221,000	-16,646,000	-16,747,000	-13,671,000	-9,978,000	-9,010,000	-8,280,000	-7,513,000	-6,542,000	-8,787,000	-7,707,000	-9,936,000	-13,111,000	-10,706,000	-9,796,000	-12,321,000	-11,402,000	-13,163,000	-10,867,000	-10,320,000	-11,284,000	-9,529,000	-8,472,000	-9,294,000	-17,243,000	-15,079,000	-8,471,000	-7,028,000	-5,160,000	-5,485,000	-6,255,000	-4,300,000	-4,715,000	-6,590,000	-11,252,000	-5,836,000	-6,288,000	-5,183,000	-3,719,000	-2,776,000	-3,595,000	-3,011,000	-5,030,000	-4,839,000	-3,556,000	-5,207,000	-5,505,000	-5,121,000	-5,579,000	-11,684,000	-2,905,000	-1,654,000	-1,538,000	-1,185,000	-1,647,000	-3,886,000	-3,519,000	-2,895,000	-4,127,000	-4,799,000	-4,975,000	-3,075,000	-5,859,000	-2,298,000	-3,245,000	-2,706,000	-3,107,000	-2,801,000	-2,555,000	-2,847,000	-2,220,000	-2,518,000	-1,788,000	-999,000	-746,000	-233,000	-2,797,000	-381,000	-87,000	-190,000	-207,000
purchase of marketable securities	-9,630,000	-7,537,000	-8,024,000	-12,711,000	-11,181,000	-5,054,000	-11,134,000			0	-1,445,000	-12,777,000	-39,308,000	-12,701,000	-15,244,000	-27,504,000	-26,566,000	-48,442,000	-14,485,000	-21,356,000	-19,216,000	-44,482,000	-35,255,000	-2,226,000	-1,600,000	-804,000	-133,000	-7,143,000	-1,396,000	-2,000,000	-724,000	-2,138,000	-4,600,000	-1,010,000	0	-4,096,000	-5,430,000	-121,000	-1,266,000	-19,894,000	-9,116,000	-91,000	-611,000	-17,822,000	-4,319,000	-4,355,000	-496,000	-2,637,000	-20,662,000	-6,178,000	-11,443,000	-11,761,000	-21,055,000	-6,224,000	-18,648,000	-8,318,000	-22,528,000																-11,022,000	-16,000	-4,208,000	-1,070,000	-5,576,000	-288,000	-644,000	-1,722,000	-7,544,000	-247,000	-1,476,000	1,174,000	-7,266,000
proceeds from sales/maturities of marketable securities	13,543,000	8,493,000	8,127,000	16,950,000	8,351,000	7,862,000	8,407,000	11,723,000	18,008,000	12,181,000	16,511,000	21,574,000	15,612,000	25,539,000	28,208,000	15,617,000	23,108,000	16,290,000	21,050,000	17,794,000	14,549,000	44,691,000	229,000	1,417,000	1,599,000	224,000	4,634,000	683,000	8,240,000	127,000	242,000	539,000	1,734,000	282,000	28,394,000	375,000	13,764,000	229,000	5,077,000	8,396,000	16,364,000	8,829,000	3,301,000	1,420,000	7,812,000	1,052,000	4,512,000	4,732,000	34,179,000	3,733,000	17,015,000	11,322,000	19,441,000	7,715,000	12,616,000	3,971,000	18,879,000
proceeds from life insurance policies	7,000	6,747,000	0	519,000	93,000	0	6,940,000	0	9,332,000	1,680,000	1,646,000	1,000,000	50,000	0	219,000	886,000	2,277,000	10,341,000	7,775,000	0	591,000	0	281,000	326,000	1,673,000	660,000	2,455,000	4,432,000	85,000	180,000	4,204,000	0	971,000					703,000	894,000	0	1,659,000	0	6,111,000	175,000	1,801,000
premium on company-owned life insurance policies	-13,502,000	-227,000	-14,699,000	-12,000	-13,502,000	-232,000	-14,702,000	-13,000	-238,000	-221,000	-14,709,000	-13,000	-276,000	-928,000	-13,995,000	-18,000	-277,000	-987,000	-14,005,000	-14,000	-347,000	-251,000	-15,093,000	-14,000	-341,000	-250,000	-860,000	-33,354,000	-398,000		-917,000	-19,000	-403,000		-917,000	-19,000	-401,000			-15,000	-404,000
net cash from investing activities	-32,181,000	-12,817,000	-76,422,000	-9,524,000	-26,736,000	-9,284,000	-22,238,000	-33,749,000	11,443,000	-158,121,000	-15,179,000	-109,759,000	-40,418,000	-47,779,000	-105,283,000	-20,917,000	-10,353,000	-31,078,000	-6,973,000	-10,118,000	-13,210,000	-7,689,000	-168,256,000	-13,608,000	-9,209,000	-9,966,000	-6,085,000	-46,784,000	-6,632,000	-12,655,000	-7,515,000	-12,902,000	-11,767,000	-8,234,000	18,408,000	-20,983,000	-9,796,000	-7,229,000	-254,500,000	-16,673,000	3,824,000	-13,104,000	4,901,000	-20,970,000	-1,397,000	-14,281,000	-1,385,000	-4,212,000	-3,714,000	-6,453,000	-67,142,000	-38,486,000	-4,630,000	-4,613,000	-10,685,000	-8,596,000	-9,133,000	-15,257,000	-12,337,000	-30,679,000	-22,858,000	-3,464,000	-6,600,000	-2,759,000	-10,621,000	-2,763,000	-10,326,000	-4,053,000	-10,638,000	1,585,000			-16,437,000	-6,277,000	-8,582,000	-25,471,000	-8,192,000	-3,513,000	-3,221,000	-4,054,000	-10,953,000	-1,389,000	-4,856,000	-672,000	-9,007,000	5,565,000	1,610,000	-3,377,000	-4,277,000	-174,000	-2,569,000	-218,000
cash flows from financing activities:
dividends paid to stockholders	-26,209,000				-19,800,000				-9,627,000
repurchases of common stock	-10,298,000	-14,899,000	-17,767,000	-32,665,000	-23,488,000	-23,034,000	-20,601,000	-4,389,000	-5,138,000	-13,007,000	-25,565,000	-32,506,000	-24,385,000	-67,309,000	-19,563,000	-6,922,000	-2,464,000	0	-7,617,000			-24,391,000	-6,126,000	-49,191,000	-12,738,000	0	-14,627,000			-503,000	-3,307,000	-25,235,000	-4,026,000	-12,503,000
payments of tax withholdings on restricted stock	-18,704,000	-298,000	-69,000	-359,000	-16,625,000	-123,000	-58,000	-376,000	-10,175,000	-96,000	-76,000	-190,000	-21,870,000	-288,000	-186,000	-431,000	-17,627,000	-277,000	-162,000	-108,000	-4,442,000	-131,000	-137,000	-134,000	-8,591,000	-201,000	-7,313,000	-130,000	-13,054,000		-196,000	-115,000	-3,346,000		-200,000
proceeds from issuance of common stock in connection with an employee stock purchase plan	4,158,000	0	3,620,000	0	4,248,000
principal payments on finance leases	-499,000	-420,000	-396,000	-403,000	-412,000	-415,000	-423,000	-556,000	-382,000	-411,000	-414,000	-402,000	-412,000	-297,000	-268,000	-303,000	-289,000	-300,000	-360,000	-333,000	-331,000	-407,000	-499,000	-495,000	-432,000
net cash from financing activities	-51,552,000	-44,281,000	-35,394,000	-54,978,000	-56,077,000	-41,057,000	-36,627,000	-18,023,000	-20,626,000	-22,061,000	-34,056,000	-45,014,000	-51,049,000	-74,611,000	-24,777,000	-14,403,000	-23,653,000	-11,080,000	-18,625,000	-29,376,000	-7,805,000	-30,435,000	105,537,000	-6,494,000	-24,927,000	-6,866,000	-30,319,000	-6,853,000	-20,587,000	-12,700,000	-11,513,000	-37,779,000	-15,266,000	-24,736,000	-19,376,000	-18,068,000	126,622,000	-13,731,000	143,072,000	-4,493,000	-6,396,000	-4,355,000	-2,361,000	573,000	-1,792,000		4,138,000	2,050,000	-26,000			864,000	-2,327,000	864,000	310,000			6,374,000	7,714,000	-1,023,000	-7,116,000	3,151,000	2,222,000	-1,314,000	4,037,000	-889,000	81,000	-4,580,000	-294,000	119,000	-5,612,000	-35,433,000	-464,000	-27,308,000	9,718,000	10,165,000	-18,594,000	-15,187,000	9,793,000	1,376,000	5,172,000	3,635,000	5,580,000	-498,000	8,377,000	-4,409,000	-2,568,000	865,000	380,000	-658,000	5,021,000	-8,368,000
effect of exchange rate changes on cash and cash equivalents	-1,009,000	28,951,000	-17,472,000	3,978,000	2,369,000	-7,307,000	10,825,000	-22,192,000	1,855,000	1,198,000	35,731,000	-24,279,000	-14,933,000	-26,226,000	-12,827,000	-6,614,000	-6,923,000	1,680,000	20,262,000	-2,395,000	18,819,000	-15,552,000	769,000	2,067,000	-5,668,000	-4,165,000	5,088,000	-9,716,000	-10,408,000	-3,320,000	10,641,000	-2,126,000	7,743,000	174,000	-83,000	-2,395,000	-9,967,000	5,418,000	-8,043,000	-1,357,000	-11,559,000	4,655,000	-16,379,000	-8,018,000	-1,908,000	4,395,000	-6,280,000	2,642,000	-2,571,000	-2,345,000	997,000	2,969,000	-4,146,000	506,000	-2,741,000	-3,843,000	1,093,000	5,438,000	481,000	3,699,000	-2,447,000	3,819,000	-777,000	1,858,000	5,527,000
net decrease in cash and cash equivalents	-322,109,000		84,448,000	61,474,000	-307,629,000		115,961,000	58,627,000	-281,815,000		177,998,000	-45,884,000	-338,286,000			76,087,000	-201,474,000			10,323,000	-146,458,000		99,285,000	39,786,000	-201,723,000		101,830,000	21,950,000	-155,119,000			606,000	-128,863,000			5,960,000	-29,179,000		-63,401,000	-5,771,000	-104,324,000			9,617,000	-95,144,000			32,202,000	-73,640,000		-24,681,000	-3,456,000	-85,633,000		26,027,000	35,232,000	-89,919,000		30,191,000	5,102,000	-73,217,000		-7,127,000	-4,631,000	-67,431,000												-72,124,000				-53,118,000				-21,815,000					1,704,000	-7,336,000
cash and cash equivalents at beginning of period	1,006,964,000		0	0	941,005,000		0	0	844,024,000		0	0	978,070,000		0	0	850,778,000		0	0	689,244,000		0	0	626,360,000		0	0	520,848,000		0	0	410,882,000		0	0	273,252,000		0	0	380,838,000		0	0	333,717,000		0	0	224,066,000		0	0	282,005,000		0	0	246,856,000		0	0	219,233,000		0	0	255,000,000
cash and cash equivalents at end of the period	684,855,000		84,448,000	61,474,000	633,376,000		115,961,000	58,627,000	562,209,000		177,998,000	-45,884,000	639,784,000	131,565,000	121,114,000	76,087,000	649,304,000	156,650,000	141,019,000	10,323,000	542,786,000	125,536,000	99,285,000	39,786,000	424,637,000	136,851,000	101,830,000	21,950,000	365,729,000																																						18,258,000	-6,721,000	205,949,000		56,746,000	-32,668,000	199,576,000		47,532,000	15,844,000	185,419,000		41,419,000	24,851,000	146,015,000		33,122,000	29,932,000	86,287,000		12,503,000		7,907,000	1,704,000	58,792,000
impairment of right-of-use assets		0				0	0	0	1,629,000	0
impairment of fixed assets		0				0	0	1,452,000	123,000	0				0	0
cash paid for acquisitions, net of cash acquired		0								-155,428,000	0			-42,942,000																																																	-8,252,000	267,000	-10,251,000	0					-505,000	-955,000	-2,800,000		-2,547,000
dividends received from unconsolidated subsidiaries		0	0							0	0	0	150,000	0	60,000	80,000	115,000	0				60,000	120,000	0	166,000	0				180,000	0	0	60,000	109,000	225,000	0	230,000	243,000	1,324,000	0	806,000	0	1,338,000	0	318,000	170,000	1,440,000	0	510,000	0	1,479,000	0	418,000	0	1,529,000	0	140,000	0	1,017,000	339,000	252,000	801,000	0	0	157,000	0	1,153,000	1,458,000	341,000	141,000	1,755,000	139,000	888,000	251,000	1,542,000	123,000	513,000	190,000	1,296,000
dividends paid to shareholders		-25,056,000	-19,314,000			-17,485,000	-17,617,000			-8,031,000	-8,066,000	-8,171,000	-8,703,000	-6,572,000	-6,665,000	-6,683,000	-6,866,000	-5,544,000	-5,540,000	-5,607,000	-5,807,000	-5,506,000	-5,583,000	-5,628,000	-6,081,000	-5,701,000	-6,015,000	-5,716,000	-6,027,000	-5,713,000	-5,705,000	-5,714,000	-5,823,000	-5,772,000	-5,796,000	-5,841,000	-5,909,000	-5,774,000	-5,770,000	-5,174,000	-5,115,000
payments on life insurance policy loans		-3,608,000	0			0				-516,000	-1,582,000	-612,000	-50,000	0	-114,000			-4,402,000	-7,281,000	0	-596,000	0	0	0	-943,000	-965,000	-1,784,000			-90,000	-50,000	0	-414,000					0	-100,000	0	-1,151,000	0	-2,596,000	0	-705,000																					-403,000	0	0	-367,000	0												627,000	-3,583,000	0	-308,000	-7,371,000	-4,396,000
dividends paid to noncontrolling interest														-145,000				-557,000
net increase in cash and cash equivalents														131,565,000				156,650,000												130,858,000				59,577,000								76,387,000				85,933,000																																45,258,000	41,419,000			49,792,000	33,122,000			31,196,000		14,282,000
cash and cash equivalents at beginning of year
cash and cash equivalents at end of the year
supplemental cash flow information:
cash used to pay interest
cash used to pay income taxes, net of refunds
dividends - noncontrolling interest			-1,468,000				-1,456,000				-1,588,000											0	-1,064,000			0	-1,565,000
(gain) loss on marketable securities																																		-3,752,000	-3,864,000														-1,941,000
proceeds from issuance of common stock upon exercise of employee stock options and in connection with an employee stock purchase plan							3,651,000	0	4,696,000	0	3,235,000	0	4,371,000	0	3,326,000	0	3,593,000	0	2,335,000	0	3,371,000	0	3,371,000	0	4,313,000	1,000	3,166,000	0	4,105,000	0	2,901,000	0	3,984,000	140,000	2,367,000	184,000	2,430,000	66,000	1,481,000	112,000	2,379,000	816,000	293,000	405,000	1,479,000	1,432,000	3,519,000	2,032,000	1,822,000	791,000	324,000	846,000	173,000	972,000	268,000	22,000	3,109,000	2,069,000	6,010,000	512,000	1,493,000	566,000	1,969,000	372,000	3,619,000	129,000	996,000	723,000	1,761,000		2,249,000	851,000	14,077,000		6,070,000	7,582,000	5,964,000		8,761,000	2,571,000	5,502,000		7,244,000	1,351,000	7,378,000
loss on marketable securities
adjustments to reconcile net income to net cash used by operating activities:
impairment of right of use assets															0
impairment of right to use assets
proceeds from long term debt																						600,000,000	395,500,000			0
principal payments on long term debt																						-600,000,000
payment of debt issuance costs																						0				0
payment of contingent consideration from acquisitions																						0	0	0	-455,000	0	0	0	-455,000																				-15,000,000									-3,000,000	-800,000
tradename write-offs																												0	106,555,000
write-off of long-lived assets																						0
borrowings under life insurance policies																										0	0																											2,000	2,000	3,000	359,000	4,415,000	1,135,000	142,000	347,000	248,000	2,033,000	121,000	3,098,000	262,000	1,033,000	15,000	411,000	264,000	1,037,000	15,000	412,000	264,000	1,070,000	-35,000	312,000	294,000	1,040,000	18,000	416,000	523,000	1,998,000	79,000	1,514,000	2,186,000
cash paid for acquisition, net of cash acquired																																			0	0	-2,880,000
principal payments on term loan																										0
net cash used by operating activities																									-161,919,000
impairment of tradenames																										0
investment in unconsolidated subsidiaries																										-120,000	-62,000	-100,000	-29,000	-110,000	-97,000	-60,000	-30,000	-112,000	-113,000	-29,000	-79,000	-185,000	-181,000	-540,000	-725,000	-485,000	-778,000	-452,000	-466,000	-677,000	-470,000	-557,000	-465,000	-543,000	-593,000	-344,000	-630,000	-578,000	-293,000	-472,000	-507,000	-354,000	-534,000	-512,000	-462,000	548,000	-390,000	-226,000	-23,000	-49,000	1,408,000	-2,408,000	-1,316,000	-1,057,000	-867,000	-1,110,000	-1,146,000	-825,000	-947,000	-964,000	-932,000	-933,000	-755,000	-736,000	-736,000	-1,290,000	-304,000	304,000	-386,000	-108,000	-171,000	-171,000	155,000	-98,000	-511,000
principal payments on term loan facility																												-6,875,000	-5,156,000
change in other assets and liabilities, net of effect of acquisitions:
cash paid for acquisitions, net of cash acquired and earnout
acquisition of mexico subsidiary, net of cash acquired
premiums on company-owned life insurance policies																																						-271,000					-938,000	-28,000	-419,000	-284,000
proceeds from term loan facility																																		0	0	0	275,000,000	0
principal payment on term loan facility																														-5,156,000	-5,156,000	-5,157,000	-5,156,000	-5,156,000	-5,157,000	-5,156,000	-140,000,000	-7,500,000
payment of contingent consideration from acquisition																														0	0	0	-485,000	0	0	0	-1,070,000									0	0
payment of tax withholdings on restricted stock
dividends – noncontrolling interest																														-1,101,000	0			26,000
cash and cash equivalents at end of year
income tax and other receivables																															11,652,000	3,723,000	-10,930,000		-373,000	5,217,000	-8,093,000		-1,546,000	-10,637,000	1,145,000		7,004,000	-6,090,000	152,000		-2,243,000	-156,000	2,481,000		-5,032,000	-2,009,000	235,000
cash and cash equivalents at end of period																															107,365,000	606,000	282,019,000		101,272,000	5,960,000	244,073,000		-63,401,000	-5,771,000	276,514,000		56,261,000	9,617,000	238,573,000		65,156,000	32,202,000	150,426,000		-24,681,000	-3,456,000	196,372,000		26,027,000	35,232,000	156,937,000		30,191,000	5,102,000	146,016,000		-7,127,000	-4,631,000	187,569,000
acquisition of mexico subsidiary, cash acquired
tax benefit related to stock-based compensation																																		27,000	17,000	-299,000	332,000	178,000	74,000	592,000	4,064,000
adjustments to reconcile net income to net cash provided (used) in operating activities:
repurchases of common stock – repurchased program
purchase of common stock																																					-4,161,000	-701,000	-113,000	-23,000	-6,573,000	-196,000	-94,000	-17,000	-3,731,000	-223,000	-59,000	-22,000	-1,945,000	-165,000	-30,000	-144,000	-2,499,000	-98,000	-19,000	-84,000	-4,014,000	-427,000	-27,000	-2,266,000	-11,124,000	-1,483,000	-291,000	-132,000	-1,230,000	-49,000	-1,957,000	-5,446,000	-2,136,000	-1,545,000	-8,085,000	-36,681,000	-17,851,000	-31,685,000	-13,000	-53,000	-25,871,000	-18,713,000	-10,000	-1,216,000	-748,000	-1,145,000	0	-1,967,000	-374,000
acquisition of mexican subsidiary, cash acquired
change in restricted cash																																														0	0	0	2,861,000	0
tax benefit from exercise of stock options																																										130,000	36,000	185,000	1,165,000	-1,408,000	678,000	40,000	97,000	91,000	42,000	162,000	-1,000									4,003,000	-1,489,000	-1,675,000	-1,450,000	-823,000	7,000	126,000	36,000	1,139,000	197,000	380,000	2,896,000	753,000	2,590,000	2,668,000	1,000,000	2,229,000	1,455,000	894,000	1,292,000	559,000	1,495,000	217,000	1,566,000							0
change in fair value of acquisition-related contingent consideration																																																						0	0			-3,041,000	0
purchase of intangible assets																																																						0								0	0
payment of purchase price held back from previous acquisition																																																						0	0
net cash provided (used in) by financing activities
cash used to pay income taxes
change in other assets and liabilities, net of effects of acquisition:
premiums on life insurance policies																																																-19,000	-419,000	-289,000	-1,012,000	-15,000	-423,000	-293,000	-1,011,000	-18,000	-417,000	-292,000	-1,047,000	-13,000	-350,000	-261,000	-1,011,000	-14,000	-425,000	-302,000	-1,040,000	-14,000	-425,000	-310,000	-1,041,000	-56,000	-428,000	-310,000	-1,071,000	-40,000	-423,000	-308,000	-1,072,000	-44,000	-429,000	-312,000	-862,000	-58,000	-662,000
impairment of intangible assets
cash paid for acquisitions, net of cash acquired and contingent consideration
proceeds from exercise of warrants																																																										0	0	0	2,983,000
payment of dividends by majority owned consolidated subsidiaries																																																										-300,000
net cash (used) provided in operating activities
cash paid for acquisitions, net of cash acquired and earn-outs
net cash (used) provided by financing activities
(gain) loss on marketable securities classified as trading
loss on marketable securities classified as trading																																																					831,000				1,625,000
(gain) loss on disposition of property and equipment																																																						8,000	30,000																												-3,000
gain on marketable securities classified as trading																																																						-2,967,000	-2,162,000			-3,412,000	-2,355,000	-3,252,000	1,420,000	-3,611,000	-1,411,000	-2,015,000	-4,100,000
receivables, including income tax and other receivables
tax benefit (expense) from exercise of stock options																																																								-33,000	1,650,000	617,000
receivables and income tax and other receivables
proceeds from sales of property and equipment																																																							-7,000
receivables																																																								4,583,000	-24,957,000	13,603,000	2,543,000	-18,995,000	-25,291,000	1,088,000	-6,006,000	-15,865,000	-12,733,000	26,103,000	27,590,000	10,794,000	-19,848,000	17,962,000	3,432,000	-18,840,000	-25,768,000	13,392,000	-10,089,000	-11,699,000	-17,570,000	6,382,000	-7,215,000	-2,905,000	-15,721,000	8,954,000	-6,383,000	-8,598,000	-16,410,000	2,394,000	-3,869,000	1,436,000	4,122,000	626,000	14,624,000	3,292,000
prepaid expenses																																																								780,000	-2,697,000	-1,764,000	42,000	-357,000	-4,417,000	-1,889,000	2,455,000	-1,276,000	-3,488,000	432,000	2,487,000	-1,703,000	-2,556,000	-1,140,000	-646,000	-777,000	-580,000	-1,195,000	-114,000	995,000	-2,018,000	-458,000	-75,000	-633,000	857,000	-388,000	-1,384,000	-756,000	-1,054,000	-32,000	-122,000	24,000	819,000	-138,000	-777,000	1,886,000
loss on disposition of property and equipment																																																									12,000	3,000	-5,000	22,000	60,000	121,000	-235,000	-78,000	515,000	3,492,000	163,000	64,000	21,000		5,000	-36,000	161,000																	-107,000	138,000	-12,000
net cash provided (used) in financing activities																																																									1,104,000
(gain) loss on cash surrender value of life insurance policies																																																														-2,883,000	-1,479,000	-1,817,000	-3,379,000
realized loss on available-for-sale marketable securities
other-than-temporary impairment on available-for-sale securities, net of unrealized gains reclassified to other income upon the transfer of available-for-sale securities to trading
(purchase of) proceeds from marketable securities																																																											-6,386,000	-24,106,000	-10,401,000					-814,000	6,347,000	-1,978,000	-7,659,000
tax expense from exercise of stock options																																																												589,000	-815,000
payment of earn-outs from acquisitions																																																													-675,000
realized gain on available-for-sale marketable securities
proceeds from (purchase of) marketable securities																																																														1,804,000	4,317,000	2,007,000	1,083,000
other-than temporary impairment on marketable securities
realized loss on available-for sale marketable securities
realized gain on available-for sale marketable securities
interest paid in kind and amortization of discount on convertible securities																																																																										325,000	99,000	244,000	247,000	384,000	99,000	246,000	246,000	237,000	246,000	-245,000	1,177,000	1,137,000
realized gain on marketable securities																																																																		3,776,000	22,000
supplemental non-cash investing and financing activities:
conversion of debt to equity
cash from operating activities:
cash from investing activities:
cash from financing activities:
receipts on stockholders’ notes																																																																			2,000	2,000	1,000	2,000	2,000	2,000	2,000	1,000	1,000	3,000	1,000	17,000	2,000	3,000	2,000	-100,000	-79,000	39,000	167,000
effect of exchange rates on cash and cash equivalents																																																																			-614,000	-22,888,000	456,000		3,524,000	4,475,000	757,000		2,023,000	-2,263,000	1,756,000		90,000
net decrease in cash and cash equivalents during the period																																																																			18,258,000	-6,721,000	-99,347,000		56,746,000	23,907,000	-89,530,000
cash and cash equivalents at beginning of the period																																																																			0	0	305,296,000		0	-56,575,000	289,106,000		0	0	257,543,000		0	0	199,133,000		0	0	108,102,000		0		0	0	66,128,000
stock compensation expense																																																																					4,211,000		459,000	599,000	871,000	1,318,000	1,085,000	1,397,000	1,895,000
realized gains on marketable securities																																																																					-237,000	-1,542,000	-3,186,000	-810,000	-17,000	-303,000	-1,440,000				-606,000	-100,000	-358,000
gain on disposition of property and equipment																																																																														7,000	9,000	4,000	39,000				-10,000
gains on cash surrender value of life insurance policies																																																																																					-1,000,000	-898,000
recovery on investment loss																																																																														-150,000
deferred income tax benefit																																																																																						-2,247,000	-340,000
non cash compensation arrangements
cash paid for acquisitions, net of cash required
proceeds from issuance of common stock upon exercise of employee stock options and in connection with employee stock purchase plan
cash and cash equivalents at beginning of the year
supplemental disclosures of consolidated cash flow information:
cash paid for interest
cash paid for income taxes
supplemental disclosures of non-cash investing and financing activities:
amortization of discount on convertible securities
non-cash compensation arrangements																																																																							3,378,000	3,591,000	3,033,000		2,463,000	2,333,000	1,118,000		1,519,000	979,000	1,532,000		-71,000
sales (purchase) of marketable securities
proceeds from sales of marketable securities
net cash from (used) in investing activities
proceeds from life insurance policy benefits																																																																																		398,000	0	0	339,000
proceeds from sale of equity securities
effect of exchange rate changes on cash & cash equivalents
net increase in cash and cash equivalents during the period
business acquisitions																																																																														0	0	-38,000	-1,011,000	0	0	0	-419,000
realized gains on marketable and equity securities
asset impairment charges
proceeds from surrender of life insurance policies																																																																																						6,903,000
purchase of futurestep minority shares																																																																																						0	0
payment of acquisition notes
effect of exchange rate changes on cash flows																																																																																	-707,000	-2,131,000	470,000	3,216,000	523,000	1,145,000	96,000	1,032,000	-1,077,000	-76,000	-3,028,000
net cash (used in)/provided by operating activities
proceeds from dividends on mexico investment																																																																																	878,000
realized (gains) loss on marketable and equity securities
restructuring charges
proceeds from issuance of convertible debt, preferred stock and warrants
payments on previous credit facility
asset impairment charge																																																																																							0		315,000
surrender of life insurance policies
deferred income tax																																																																																					-1,023,000
restricted stock compensation																																																																																					487,000	538,000	476,000	320,000	289,000	339,000	346,000	543,000
variable stock-based compensation																																																																																					94,000
income taxes																																																																																					899,000			98,000	-555,000	1,049,000	-124,000	-4,178,000
dividends paid on preferred stock
depreciation																																																																																						2,174,000	2,527,000	3,534,000	3,673,000	3,784,000	3,871,000	3,831,000
amortization of intangible assets																																																																																						23,000	19,000	335,000	326,000	278,000	360,000
amortization of note payable discount																																																																																								0	80,000	80,000	84,000	100,000
unrealized loss on marketable securities and other assets																																																																																										63,000	290,000
sale of marketable securities																																																																																												545,000
business acquisitions, net of cash acquired																																																																																												-321,000
premiums on life insurance
proceeds from life insurance policy benefit payments
(payments) borrowings on previous credit facility
proceeds from issuance of common stock and receipts on stockholders’ notes																																																																																						1,692,000
loss(gain) on disposition of property and equipment
restructuring charge																																																																																									0
change in other assets and liabilities
proceeds from life insurance
payment of shareholder acquisition notes																																																																																							0	0	-4,400,000	-472,000	-4,656,000	-1,179,000
purchase of common stock and payment on related notes																																																																																							-293,000		-813,000	-420,000	-65,000
interest paid in kind and amortization on convertible securities
cash surrender value gains
change in other assets and liabilities, net of acquisitions:
issuance of convertible debt, preferred stock and warrants																																																																																								0	-51,000	-43,000	45,722,000
net borrowings under life insurance policies																																																																																								531,000	5,641,000	50,000	2,507,000	1,211,000
issuance of common stock and receipts on stockholders’ notes
interest paid in kind and amortization on convertible debt discount
cash surrender value gains and benefits in excess of premiums paid
premiums paid on life insurance, net of benefits received
net cash from provided by financing activities
adjustments to reconcile net income to net cash from provided by operating activities:
amortization of goodwill
interest paid in kind and amortization on convertible debt
cash surrender value (gains) losses and benefits in excess of premiums paid																																																																																										-197,000	-197,000
premiums on life insurance, net of benefits received																																																																																								-580,000	-3,896,000	-87,000	-2,379,000	-235,000
purchase of investments
net (repayments) borrowings on previous credit facility																																																																																								0
purchase of common stock and payment of related notes
issuance of common stock and receipts on shareholders’ notes																																																																																								151,000	3,000	227,000	513,000	600,000
interest, dividends and amortization on convertible debt and preferred stock																																																																																									872,000	872,000	446,000
deferred income tax provision																																																																																									-70,000	1,378,000	-977,000
net (repayments) borrowings on credit line																																																																																										0	-39,000,000
amortization of other intangible assets
unrealized loss on marketable securities
restructuring charges, including 12,578 of liabilities
net borrowings (repayments) on credit line
effect of foreign currency exchange rate changes on cash flows
restructuring charge, including 12,889 in accrued liabilities
non-controlling shareholders’ interest and other
purchases of marketable securities
net borrowings on credit line

We provide you with 20 years of cash flow statements for Korn Ferry stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Korn Ferry stock. Explore the full financial landscape of Korn Ferry stock with our expertly curated income statements.

The information provided in this report about Korn Ferry stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.